Entero Healthcare Solutions Limited – Investor Presentation Summary

Key Operational Highlights

  • Pan-India presence through 136 warehouses in ~50 cities and 520+ districts across 20+ states & Union Territories
  • Completed 7 acquisitions during FY26, including 3 in MedTech segment
  • MedTech segment including three acquisitions closed in FY26 is expected to contribute more than ₹1,000 Cr in FY27
  • Amongst the top three healthcare products distributors in India in terms of revenue

Key drivers of operational performance: Market consolidation through acquisitions, geographic expansion, and technology integration

Segment-wise Performance

Not Specified

Financial Highlights

Revenue: ₹6,594.2 Cr (FY26)

EBITDA: ₹266.0 Cr (FY26)

PAT: ₹145.8 Cr (FY26)

EPS: ₹26.44 (Basic, FY26)

Margins: Gross Margin 10.3% (FY26), EBITDA Margin 4.0% (FY26), PAT Margin 2.2% (FY26)

YoY/QoQ comparison: Revenue growth 29.3% YoY, EBITDA growth 55.0% YoY, PAT growth 35.7% YoY

Drivers of financial performance: Higher revenue growth, margin expansion, working capital efficiency improvements

Comparison to market estimates: Not Specified

Key Risks: Not Specified

Geographical Revenue Split

Domestic vs Export/Regional Revenue: Not Specified

Regional Breakdown: Not Specified

Balance Sheet Snapshot

Net Debt/Equity: Not Specified

Reserves: ₹1,645.1 Cr (Mar-26)

Current Assets/Liabilities: Current Assets ₹2,508.4 Cr, Current Liabilities ₹1,587.6 Cr (Mar-26)

Working Capital/Leverage Metrics: Net Operating Working Capital Days improved to 59 days in Q4FY26 from 64 days in previous quarter

Financial Health Insights: Improved cash flow generation, positive operating cash flow of ₹96.2 Cr in FY26

Capex & Cash Flow Health

Capital Expenditure: Not Specified

Free Cash Flow: Not Specified

Operating Cash Flow: ₹96.2 Cr (FY26)

Net Debt Movement: Not Specified

Investment Rationale: Focus on capacity expansion through acquisitions, technology upgrades

Strategic & R&D Initiatives

Investments in Innovation: Proprietary technology platform with integrated business intelligence tools, hub and spoke distribution model

Expected impact on growth: Technology platform provides real-time visibility of products, pricing, inventory levels, and order status

Strategic Rationale: Expanding into high-growth MedTech markets, reducing operational costs through technology

Industry Trends & Business Environment

Macro/Industry Trends: Healthcare distribution market consolidation, shift from standalone/traditional distributors to large/national distributors

Impact on Company: Entero positioned to benefit from market consolidation trend with share of large/national distributors expected to rise to 20-30% by FY28

Management Commentary & Growth Outlook

Strategic Outlook: "FY26 marks a year of significant progress on our vision to build a scalable, comprehensive and integrated healthcare distribution platform. We also expanded beyond pharma and made meaningful strides in MedTech which broadens our addressable opportunity and strengthens our platform for the long term." - Prabhat Agrawal, Promoter, MD and CEO

FY Guidance: Revenue Growth 23.0% YoY, EBITDA Margin 5.0%, Operating Cashflow to EBITDA Conversion Ratio 50% (Revenue growth doesn't factor in new acquisitions)

Market Share Targets: Not Specified

Risks and Opportunities: Not Specified